ATE438413T1 - Integrin-vermittelte arzneimittel-zielrichtung - Google Patents
Integrin-vermittelte arzneimittel-zielrichtungInfo
- Publication number
- ATE438413T1 ATE438413T1 AT00965901T AT00965901T ATE438413T1 AT E438413 T1 ATE438413 T1 AT E438413T1 AT 00965901 T AT00965901 T AT 00965901T AT 00965901 T AT00965901 T AT 00965901T AT E438413 T1 ATE438413 T1 AT E438413T1
- Authority
- AT
- Austria
- Prior art keywords
- sub
- integrin
- drug targeting
- cytostatic
- beta
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 230000008685 targeting Effects 0.000 title 1
- 239000000824 cytostatic agent Substances 0.000 abstract 3
- 230000001085 cytostatic effect Effects 0.000 abstract 3
- 229940123038 Integrin antagonist Drugs 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 230000002255 enzymatic effect Effects 0.000 abstract 1
- 230000003301 hydrolyzing effect Effects 0.000 abstract 1
- 102000006495 integrins Human genes 0.000 abstract 1
- 108010044426 integrins Proteins 0.000 abstract 1
- 230000003834 intracellular effect Effects 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
- 210000004881 tumor cell Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39216799A | 1999-09-08 | 1999-09-08 | |
| US60677200A | 2000-06-29 | 2000-06-29 | |
| PCT/EP2000/008361 WO2001017563A2 (en) | 1999-09-08 | 2000-08-28 | Integrin-mediated drug targeting |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE438413T1 true ATE438413T1 (de) | 2009-08-15 |
Family
ID=27013781
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00965901T ATE438413T1 (de) | 1999-09-08 | 2000-08-28 | Integrin-vermittelte arzneimittel-zielrichtung |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20060189544A1 (de) |
| EP (1) | EP1235595B8 (de) |
| JP (1) | JP2003508497A (de) |
| CN (1) | CN1402643A (de) |
| AT (1) | ATE438413T1 (de) |
| AU (1) | AU773781B2 (de) |
| BR (1) | BR0013883A (de) |
| CA (1) | CA2383981A1 (de) |
| DE (1) | DE60042700D1 (de) |
| ES (1) | ES2330079T3 (de) |
| HU (1) | HUP0203899A3 (de) |
| MX (1) | MXPA02002488A (de) |
| NZ (1) | NZ517620A (de) |
| PL (1) | PL354268A1 (de) |
| RU (1) | RU2002109215A (de) |
| WO (1) | WO2001017563A2 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1219305A1 (de) * | 2000-12-27 | 2002-07-03 | Bayer Aktiengesellschaft | Konjugate von Integrinrezeptorantagonisten und einem zytostatischen Mittel mit spezifisch spaltbaren Linkergruppen |
| EP1238678A1 (de) * | 2001-03-08 | 2002-09-11 | Bayer Aktiengesellschaft | Enzymaktivierte cytostatische Prodrugverbindungen mit Integrin Liganden |
| ITRM20040241A1 (it) * | 2004-05-13 | 2004-08-13 | Ist Naz Stud Cura Dei Tumori | Camptotecine coniugate in posizione 20 con antagonisti delle integrine. |
| ITRM20040240A1 (it) * | 2004-05-13 | 2004-08-13 | Ist Naz Stud Cura Dei Tumori | Camptotecine coniugate in posizione 7 con antagonisti delle integrine. |
| CN105566338B (zh) * | 2014-10-08 | 2017-11-21 | 兰州大学 | 一种喜树碱类化合物及其制备方法和用途 |
| CN108456154A (zh) * | 2018-04-13 | 2018-08-28 | 昆明理工大学 | 一种n-叔丁氧羰基烃基胍的制备方法 |
| KR20240089138A (ko) * | 2021-10-04 | 2024-06-20 | 빈서스 파마 게엠베하 | 과증식성 장애의 치료, 예방, 또는 관리를 위한 화합물, 약제학적 조성물, 및 방법 |
| KR20240105377A (ko) * | 2021-10-04 | 2024-07-05 | 빈서스 파마 게엠베하 | 과증식성 질환의 치료, 예방 또는 관리를 위한 화합물, 약학 조성물 및 방법 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU680411B2 (en) * | 1992-04-03 | 1997-07-31 | Genentech Inc. | Antibodies to alphavbeta3 integrin |
| CA2241051A1 (en) * | 1995-12-21 | 1997-10-23 | The Scripps Research Institute | Targeted therapeutic or diagnostic agents and methods of making and using same |
-
2000
- 2000-08-28 DE DE60042700T patent/DE60042700D1/de not_active Expired - Lifetime
- 2000-08-28 CA CA002383981A patent/CA2383981A1/en not_active Abandoned
- 2000-08-28 BR BR0013883-5A patent/BR0013883A/pt not_active IP Right Cessation
- 2000-08-28 MX MXPA02002488A patent/MXPA02002488A/es unknown
- 2000-08-28 PL PL00354268A patent/PL354268A1/xx not_active Application Discontinuation
- 2000-08-28 AT AT00965901T patent/ATE438413T1/de not_active IP Right Cessation
- 2000-08-28 HU HU0203899A patent/HUP0203899A3/hu unknown
- 2000-08-28 CN CN00814704A patent/CN1402643A/zh active Pending
- 2000-08-28 ES ES00965901T patent/ES2330079T3/es not_active Expired - Lifetime
- 2000-08-28 AU AU76487/00A patent/AU773781B2/en not_active Ceased
- 2000-08-28 NZ NZ517620A patent/NZ517620A/en unknown
- 2000-08-28 RU RU2002109215/15A patent/RU2002109215A/ru not_active Application Discontinuation
- 2000-08-28 EP EP00965901A patent/EP1235595B8/de not_active Expired - Lifetime
- 2000-08-28 WO PCT/EP2000/008361 patent/WO2001017563A2/en active Search and Examination
- 2000-08-28 JP JP2001521351A patent/JP2003508497A/ja active Pending
-
2006
- 2006-04-07 US US11/399,985 patent/US20060189544A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20060189544A1 (en) | 2006-08-24 |
| WO2001017563A2 (en) | 2001-03-15 |
| JP2003508497A (ja) | 2003-03-04 |
| BR0013883A (pt) | 2002-05-07 |
| EP1235595B1 (de) | 2009-08-05 |
| RU2002109215A (ru) | 2003-12-10 |
| ES2330079T3 (es) | 2009-12-04 |
| PL354268A1 (en) | 2003-12-29 |
| EP1235595A2 (de) | 2002-09-04 |
| CN1402643A (zh) | 2003-03-12 |
| WO2001017563A3 (en) | 2002-07-11 |
| CA2383981A1 (en) | 2001-03-15 |
| NZ517620A (en) | 2004-02-27 |
| MXPA02002488A (es) | 2002-08-12 |
| AU773781B2 (en) | 2004-06-03 |
| HUP0203899A3 (en) | 2004-09-28 |
| EP1235595B8 (de) | 2009-10-07 |
| HUP0203899A2 (hu) | 2003-02-28 |
| AU7648700A (en) | 2001-04-10 |
| DE60042700D1 (de) | 2009-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO981944L (no) | Lipopolyaminer som transfeksjonsmidler samt farmas÷ytisk anvendelse derav | |
| BR0014078A (pt) | Inibidores de fator xa | |
| BR9916857A (pt) | 4 heteroaril diarilaminas | |
| DK0839026T3 (da) | Micellære polyether-blokcopolymerkompositioner til målretning af biologiske midler | |
| PT1093819E (pt) | Compostos e composicoes para fornecimento de agentes activos | |
| BR9811956B1 (pt) | naftiridinonas e composição farmacêutica compreendendo as mesmas. | |
| TR200102959T2 (tr) | İntegrin antagonistleri olarak ikame edilmiş bisiklik heteroaril bileşikleri | |
| BR0007514A (pt) | Macrolìdeos com atividade anti-inflamatória | |
| BR9909486A (pt) | Compostos calcilìticos | |
| SE9802208D0 (sv) | Novel compounds | |
| ATE438413T1 (de) | Integrin-vermittelte arzneimittel-zielrichtung | |
| BR9607335A (pt) | Compostos 1-aril-2-acrilamino-etano e seu uso como neuroquinina especialmente antogonistas de neuroquinina 1 | |
| YU72194A (sh) | Injekcione suspenzije sa produženim dejstvom i postupak za proizvodnju istih | |
| TR200001102T2 (tr) | İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları. | |
| IT1270618B (it) | Proteine ad attivita' antitumorale | |
| AR025796A1 (es) | Quinazolinonas | |
| DE69521122D1 (de) | 2,3,4,5-tetrahydro-1h-3-benzazepin säure-additions-salze | |
| SE9902056D0 (sv) | An integrin heterodimer and an alpha subunit thereof | |
| SE9802209D0 (sv) | Novel compounds | |
| SE9504662D0 (sv) | New compounds | |
| ES2192789T3 (es) | Derivados de hidrazono-benzazuleno, composiciones farmaceuticas y compuestos intermedios. | |
| BR9814188A (pt) | "agonistas de 5-ht1f" | |
| IT1306147B1 (it) | Derivati di principi attivi ad attivita' terapeutica e/o nutrizionalee composizioni atte alla somministrazione orale contenenti tali | |
| TR200200017T2 (tr) | Benzofuran türevleri | |
| BR0014294A (pt) | Quinazolinonas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |